Partial agonistic effect of yokukansan on human recombinant serotonin 1A receptors expressed in the membranes of Chinese hamster ovary cells

Journal of Ethnopharmacology

Volumn 127, Issue 2, 2010, Pages 306-312

  Terawaki, Kiyoshi ^a   Ikarashi, Yasushi ^a   Sekiguchi, Kyoji ^a   Nakai, Yoichiro ^a   Kase, Yoshio ^a  

^a TSUMURA AND CO   (Japan)

Author keywords

Partial agonist; Receptor binding; Serotonin 1A receptor; Uncaria hook; Yokukansan

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ANGELICA ACUTILOBA EXTRACT; ATRACTYLODES EXTRACT; BULPLEURUM FALCATUM EXTRACT; CNIDIUM OFFICINALE EXTRACT; GLYCYRRHIZA URALENSIS EXTRACT; KETANSERIN; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PORIA COCOS EXTRACT; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; UNCARIA RHYNCHOPHYLLA EXTRACT; UNCLASSIFIED DRUG; YOKUKANSAN;

ANIMAL CELL; ARTICLE; BULPLEURUM FALCATUM; CELL MEMBRANE; CHO CELL; CNIDIUM OFFICINALE; CONCENTRATION RESPONSE; DRUG MECHANISM; FEMALE; IC 50; JAPAN; MEDICINAL PLANT; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR BINDING; UNCARIA RHYNCHOPHYLLA;

ANIMALS; CELL MEMBRANE; CHO CELLS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION, PLANT; HUMANS; PROTEIN BINDING; RECEPTOR, SEROTONIN, 5-HT1A; RECOMBINANT PROTEINS; SEROTONIN AGONISTS;

CRICETULUS GRISEUS; UNCARIA;

EID: 73749085627     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.11.003     Document Type: Article

References (43)

1. Aletrino M.A., Vogels O.J., Van Domburg P.H., and Ten Donkelaar H.J. Cell loss in the nucleus raphes dorsalis in Alzheimer's disease. Neurobiology of Aging 13 (1992) 461-468
2. Ando R.D., Benko A., Ferrington L., Kirilly E., Kelly P.A., and Bangdy G. Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test. Neuropharmacology 50 (2006) 884-896
3. Araujo D.M., Lapchak P.A., Robitaille Y., Gauthier S., and Quirion R. Differential alterations of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. Journal of Neurochemistry 50 (1998) 1914-1923
4. Bjork J.M., Dougherty D.M., Moeller F.G., Cherek D.R., and Swann A.C. The effects of tryptophan depletion and loading on laboratory aggression in men: time course and a food-restricted control. Psychopharmacology (Berl) 142 (1998) 24-30
5. Bondareff W., Mountjoy C.Q., and Roth M. Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 32 (1982) 164-168
6. Caramaschi D., de Boer S.F., and Koolhaas J.M. Differential role of the 5-HT1A receptor in aggressive and non-aggressive mice: an across-strain comparison. Physiology and Behavior 90 (2007) 590-601
7. Cheng Y., and Prusoff W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochemical Pharmacology 22 (1973) 3099-3108
8. Coyle J.T., Price D.L., and DeLong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219 (1985) 1184-1190
9. Food and Drug Administration, 2005. FDA public health advisory: deaths with antipsychotics in elderly patients with behavioral disturbances. http://www.fda.gov/cder/drug/advisory/antipsychotics.htm. April 11.
10. Fuller R.W. Effects of p-chloroamphetamine on brain serotonin neurons. Neurochemical Research 17 (1992) 449-456
11. Gibb J.W., Stone D.M., Stahl D.C., and Hanson G.R. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain. NIDA Research Monographs 76 (1987) 316-321
12. Halliday G.M., McCann H.L., Pamphlett R., Brooks W.S., Creasey H., McCusker E., Cotton R.G., Broe G.A., and Harper C.G. Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation. Acta Neuropathologica 84 (1992) 638-650
13. Iwasaki K., Satoh-Nakagawa T., Maruyama M., Monma Y., Nemoto M., Tomita N., Tanji H., Fujiwara H., Seki T., Fujii M., Arai H., and Sasaki H. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. Journal of Clinical Psychiatry 66 (2005) 248-252
14. Iwasaki K., Maruyama M., Tomita N., Furukawa K., Nemoto M., Fujiwara H., Seki T., Fujii M., Kodama M., and Arai H. Effect of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies. Journal of Clinical Psychiatry 66 (2005) 1612-1613
15. Jordan S., Chen R., Koprivica V., Hamilton R., Whitehead R.E., Tottori K., and Kikuchi T. In vitro profile of and the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors. European Journal of Pharmacology 517 (2005) 165-173
16. Jung J.W., Ahn N.Y., Oh H.R., Lee B.K., Lee K.J., Kim S.Y., Cheong J.H., and Ryu J.H. Anxiolytic effects of the aqueous extract of Uncaria rhynchophylls. Journal of Ethnopharmacology 108 (2006) 193-197
17. Kanatani H., Kohda H., Yamasaki K., Hotta I., Nakata Y., Segawa T., Yamanaka E., Aimi N., and Sakai S. The active principles of the branchlet and hook of Uncaria sinensis Oliv. examined with a 5-hydroxytryptamine receptor binding assay. Journal of Pharmacy and Pharmacology 37 (1985) 401-404
18. Kanno H., Sekiguchi K., Yamaguchi T., Terawaki K., Yuzurihara M., Kase Y., and Ikarashi Y. Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behaviour of para-chloroamphetamine-injected rats. Journal of Pharmacy and Pharmacology 61 (2009) 1249-1256
19. Kaziro Y., Itoh H., Kozasa T., Nakafuku M., and Satoh T. Structure and function of signal-transducing GTP-binding proteins. Annual Review of Biochemistry 60 (1991) 349-400
20. Keele N.B. Phenytoin inhibits isolation-induced aggression specifically in rats with low serotonin. Neuroreport 12 (2001) 1107-1112
21. Kepe V., Barrio J.R., Huang S.C., Ercoli L., Siddarth P., Shoghi-Jadid K., Cole G.M., Satyamurthy N., Cummings J.L., Small G.W., and Phelps M.E. Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 702-707
22. Lai M.K., Tsang S.W., Francis P.T., Esiri M.M., Keene J., Hope T., and Chen C.P. Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease. Brain Research 974 (2003) 82-87
23. Lanctôt K.L., Herrmann N., and Mazzotta P. Role of serotonin in the behavioral and psychological symptoms of dementia. Journal of Neuropsychiatry and Clinical Neurosciences 13 (2001) 5-21
24. Mann D.M., Yates P.O., and Marcyniuk B. A comparison of changes in the nucleus basalis and locus in Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry 47 (1984) 201-203
25. May J.A., Mclaughlin M.A., Sharif N.A., Hellberg M.R., and Dean T.R. Evaluation of the ocular hypotensive response of serotonin 5-HT1A and 5-HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys. Journal of Pharmacology and Experimental Therapeutics 306 (2003) 301-309
26. Mizukami K., Asada T., Kinoshita T., Tanaka K., Sonohara K., Nakai R., Yamaguchi K., Hanyu H., Kanaya K., Takao T., Okada M., Kudo S., Kotoku H., Iwakiri M., Kurita H., Miyamura T., Kawasaki Y., Omori K., Shiozaki K., Odawara T., Suzuki T., Yamada S., Nakamura Y., and Toba K. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia. International Journal of Neuro-Psychopharmacology 12 (2009) 191-199
27. Nagaratnam N., Lewis-Jones M., Scott D., and Palazzi L. Behavioral and psychiatric manifestations in dementia patients in a community: caregiver burden and outcome. Alzheimer Disease and Associated Disorders 12 (1998) 330-334
28. Newman-Tancredi A., Chaput C., Verriele L., and Millan M.J. Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors. Neuropharmacology 35 (1996) 119-121
29. Peat M.A., Warren P.F., Bakhit C., and Gibb J.W. The acute effects of methamphetamine, amphetamine and p-chloroamphetamine on the cortical serotonergic system of the rat brain: evidence for differences in the effects of methamphetamine and amphetamine. European Journal of Pharmacology 116 (1985) 11-16
30. Pengsuparp T., Indra B., Nakagawasai O., Tadano T., Mimaki Y., Sashida Y., Ohizumi Y., and Kisara K. Pharmacological studies of geissoschizine methyl ether, isolated from Uncaria sinensis Oliv., in the central nervous system. European Journal of Pharmacology 425 (2001) 211-218
31. Popova N.K., Naumenko V.S., Plyusnina I.Z., and Kulikov A.V. Reduction in 5-HT1A receptor density, 5-HT1A mRNA expression, and functional correlates for 5-HT1A receptors in genetically defined aggressive rats. Journal of Neuroscience Research. 80 (2005) 286-292
32. Popova N.K., Naumenko V.S., and Plyusnina I.Z. Involvement of brain serotonin 5-HT1A receptors in genetic predisposition to aggressive behavior. Neuroscience and Behavioral Physiology 37 (2007) 631-635
33. Sánchez C., and Hyttel J. Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors. European Journal of Pharmacology 264 (1994) 241-247
34. Shinno H., Utami E., Okazaki S., Kawamukai T., Yasuda H., Inagaki T., and Horiguchi J. Successful treatment with Yi-Gan San for psychosis and sleep disturbance in a patient with dementia with Lewy bodies. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (2007) 1543-1545
35. Shinno H., Inami Y., Inagaki T., Makamura Y., and Horiguchi J. Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (2008) 881-885
36. Tanji H., Ootsuki M., Matsui T., Maruyama M., Nemoto M., Tomita N., Seki T., Iwasaki K., Arai H., and Sasaki H. Dementia caregivers' burdens and use of public services. Geriatrics and Gerontology International 5 (2005) 102-106
37. Terawaki K., Sekiguchi K., Yamaguchi T., Imamura S., Kanno H., Ikarashi Y., Kase Y., and Takeda S. Ameliorative effects of Yokukansan on aggressive behaviors induced by p-chloroamphetamine in rats. Japanese Journal of Neuro-Psychopharmacology 27 (2007) 285
38. Tõnissaar M., Mällo T., Eller M., Häidkind R., Kõiv K., and Harro J. Rat behavior after chronic variable stress and partial lesioning of 5-HT-ergic neurotransmission: effects of citalopram. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (2008) 164-177
39. Vergnes M., Depaulis A., and Boehrer A. Parachlorophenylalanine-induced serotonin depletion increases offensive but not defensive aggression in male rats. Physiology and Behavior 36 (1986) 653-658
40. Vergnes M., Depaulis A., Boehrer A., and Kempf E. Selective increase of offensive behavior in the rat following intrahypothalamic 5,7-DHT-induced serotonin depletion. Behavioural Brain Research 29 (1988) 85-91
41. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., and Delon M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215 (1982) 1237-1239
42. Yamamoto T., and Hirano A. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons. Annals of Neurology 17 (1985) 543-577
43. Zhu M., Bowery N.G., Greengrass P.M., and Phillipson J.D. Application of radioligand receptor binding assays in the search for CNS active principles from Chinese medicinal plants. Journal of Ethnopharmacology 54 (1996) 153-164